Vertaling van "al mammographic screening " (Frans → Nederlands) :

TERMINOLOGIE

anomalie au screening anténatal de la mère
bevindingen bij prenataal onderzoek, abnormaal

IN-CONTEXT TRANSLATIONS

16. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.
16. Tabar L, Dean PB, Kaufman CS, Duffy SW, Chen HH.

Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. preventive services task force.

25. Berrington de Gonzalez A, Reeves G. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
24. Berrington de Gonzalez A, Reeves G. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.

36. Barchielli A, Paci E, Giorgi D. Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy.
35. Barchielli A, Paci E, Giorgi D. Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy.

56. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.
57. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.

38. Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening.
39. Smith-Bindman R, Chu P, Miglioretti D, Quale C, Rosenberg R, Cutter G, et al. Physician Predictors of mammographic accuracy.